Related Experiment Video

Updated: Jun 3, 2026

Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
07:19

Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Published on: March 24, 2023

Methodologic issues in clinical trials for prevention or risk reduction in osteoarthritis

J M Jordan1, M F Sowers, S P Messier

  • 1Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC 27599-7280, USA. joanne_jordan@med.unc.edu

Osteoarthritis and Cartilage
|March 15, 2011
PubMed

Insights

Designing osteoarthritis (OA) prevention trials requires careful consideration of distinct methodological challenges. Addressing these challenges can lead to successful trials that delay or prevent OA structurally and symptomatically.

Area of Science:

  • Orthopedics and Sports Medicine
  • Clinical Trial Design
  • Preventive Medicine

Background:

  • Osteoarthritis (OA) prevention trials present unique methodological challenges compared to trials targeting prevalent disease.
  • Key considerations include precise disease definition, sensitive measurement, high-risk population identification, and intervention specifics (pharmaceutical, nutraceutical, behavioral).
  • Potential pleiotropic effects of interventions on other organ systems must also be evaluated.

Framework:

  • Prevention trials necessitate rigorous attention to participant adherence and retention due to potentially prolonged durations.
  • Challenges such as 'preventive misconception' and 'behavioral disinhibition' can impact the ability to demonstrate intervention efficacy.
  • These methodological issues do not preclude scientifically rigorous and successful trial outcomes.

Implementation:

  • Leveraging advancing technologies for measuring and predicting OA progression is crucial.
  • Integrating clinical factors with imaging, genetic, metabolic, and other biomarkers enables high-risk phenotype screening.
  • Targeting high-risk individuals allows for interventions to avoid or delay structural and symptomatic OA.

Implications:

  • Successful OA prevention trials can significantly impact public health by reducing disease burden.
  • Advances in predictive diagnostics and personalized interventions will refine future prevention strategies.
  • This approach holds promise for delaying or preventing the onset and progression of osteoarthritis.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...